Omeros is developing a deep pipeline of product candidates to treat inflammation and central nervous system disorders. We currently have six programs focused on inflammation and multiple CNS programs in development, all targeting large markets.

Our most clinically advanced product candidates in the area of inflammation are derived from our proprietary PharmacoSurgery platform, designed to improve the clinical outcomes of patients undergoing arthroscopic, ophthalmological, urological and other surgical and medical procedures. In addition to our PharmacoSurgery platform, we have two other programs in preclinical development to treat inflammatory disorders.

Our preclinical programs targeting CNS disorders broaden our pipeline and help create multiple opportunities for commercial success.

For each of our product candidates and programs, we have retained all manufacturing, marketing and distribution rights.

Product Pipeline